logo

NMTC

NeuroOne Medical·NASDAQ
--
--(--)
--
--(--)

NMTC fundamentals

NeuroOne Medical (NMTC) released its earnings on Dec 17, 2025: revenue was 2.74M (YoY 0.00%), beat estimates; EPS was -0.03 (YoY +72.73%), beat estimates.
Revenue / YoY
2.74M
0.00%
EPS / YoY
-0.03
+72.73%
Report date
Dec 17, 2025
NMTC Earnings Call Summary for Q4,2025
  • Record Growth: 163% product revenue increase to $9.1M, 56.5% gross margin, and $8.2M capital raise in FY 2025.
  • FDA Milestones: First successful OneRF trigeminal nerve ablation cases and FDA clearance for new pain management technologies.
  • Drug Delivery Breakthrough: First preclinical sales to a major pharma company, with mid-2026 commercial readiness planned.
  • Cost Efficiency: 5% YoY operating expense reduction and 71% net loss improvement.
EPS
Revenue

Revenue & Expenses

NMTC has released its 2025 Q4 earnings report, with revenue of -259.07K, reflecting a YoY change of -195.15%, and net profit of -1.62M, showing a YoY change of 51.67%. The Sankey diagram below clearly presents NMTC's revenue sources and cost distribution.

Key Indicators

NeuroOne Medical (NMTC) key financial stats and ratios, covering profitability, financial health, and leverage.
NeuroOne Medical (NMTC)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
NeuroOne Medical (NMTC)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
NeuroOne Medical (NMTC)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does NeuroOne Medical (NMTC) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track NeuroOne Medical (NMTC) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield